1094 related articles for article (PubMed ID: 16417416)
1. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
2. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
3. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
4. Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study.
Pasquale LR; Rosner BA; Hankinson SE; Kang JH
J Glaucoma; 2007; 16(7):598-605. PubMed ID: 18091177
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal hormone therapy and migraine headache.
Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.
Grodstein F; Stampfer MJ; Falkeborn M; Naessen T; Persson I
Epidemiology; 1999 Sep; 10(5):476-80. PubMed ID: 10468418
[TBL] [Abstract][Full Text] [Related]
8. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone therapy and risk of developing urinary incontinence.
Grodstein F; Lifford K; Resnick NM; Curhan GC
Obstet Gynecol; 2004 Feb; 103(2):254-60. PubMed ID: 14754692
[TBL] [Abstract][Full Text] [Related]
10. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
[TBL] [Abstract][Full Text] [Related]
12. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
13. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.
Albert CM; Chae CU; Rexrode KM; Manson JE; Kawachi I
Circulation; 2005 Feb; 111(4):480-7. PubMed ID: 15687137
[TBL] [Abstract][Full Text] [Related]
14. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.
Grodstein F; Stampfer MJ; Manson JE; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1996 Aug; 335(7):453-61. PubMed ID: 8672166
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
[TBL] [Abstract][Full Text] [Related]
17. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
Shlipak MG; Chaput LA; Vittinghoff E; Lin F; Bittner V; Knopp RH; Hulley SB;
Am Heart J; 2003 Nov; 146(5):870-5. PubMed ID: 14597937
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Salpeter S
Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
[TBL] [Abstract][Full Text] [Related]
19. Hormone therapy and coronary heart disease in young women.
Weiner MG; Barnhart K; Xie D; Tannen RL
Menopause; 2008; 15(1):86-93. PubMed ID: 17502840
[TBL] [Abstract][Full Text] [Related]
20. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
Parazzini F;
Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
